secwatch.observer — SEC 8-K summary
======================================

Issuer:     Translational Development Acquisition Corp. (TDAC)
CIK:        0001926599
Form:       8-K
Filed at:   2026-05-27T11:37:31+00:00
Accession:  0001104659-26-066599
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TDAC to merge with battery maker ProLogium at ~$3.8B enterprise value
---------------------------------------------------------------------

- Deal implies ~$3.8B valuation for ProLogium on a net cash-free basis.
- Combined company to be named ProLogium Technology and list on Nasdaq as PRLG.
- Closing requires TDAC extension, shareholder approval, and at least $250M available cash from trust.
- Founder eligible for IP compensation of up to 2.5% of fully diluted shares; lock-up periods of 6-18 months.
- ProLogium shareholders representing majority sign voting and lock-up agreements supporting the deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1926599/000110465926066599/0001104659-26-066599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1926599/000110465926066599/tm2615602d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-066599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer